¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÁö¹æ°£¿¬±¸È¸ (¿Â¶óÀÎ)KNSG NAFLD(Korean NAFLD Study Group Nonalcoholic Fatty Liver Disease) Symposium 2021 : 2021-10-16

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÁö¹æ°£¿¬±¸È¸ (¿Â¶óÀÎ)KNSG NAFLD(Korean NAFLD Study Group Nonalcoholic Fatty Liver Disease) Symposium 2021 : 2021-10-16
±³À°ÀÏÀÚ : 2021-10-16
±³À°Àå¼Ò : ¿Â¶óÀÎ °³ÃÖ  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ)KNSG NAFLD(Korean NAFLD Study Group Nonalcoholic Fatty Liver Disease) Symposium 2021
ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÁö¹æ°£¿¬±¸È¸  
´ã´çÀÚ : ´ëÇÑ°£ÇÐȸ Áغñ»ç¹«±¹
¿¬¶ôó : 02-373-1005  
À̸ÞÀÏ : kaslsecretariat@hbni.co.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 50ºÐ  
¼¼ºÎ¼ö°­·á : 40,000¿ø      
ºñ°í È¸¿ø, ÀüÀÓÀÇ, Àü°øÀÇ 30,000¿ø ºñȸ¿ø, ¿Â¶óÀÎȸ¿ø 40,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 09:00~09:20 Metabolomic Biomarkers in NAFLD  ±èÈÖ¿µ(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 09:20~09:50 Genetics-based Precision Medicine in NAFLD  Silvia Sookoian(Univ. of Buenos Aires Argentina) 
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 09:50~10:10 Role of Macrophage in NAFLD  ÇÑ¿ëÇö(°­¿ø´ë) 
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 10:10~10:30 Inflammatory Aspects of NASH Hepatocarcinogenesis  ÇöÁ¤Àº(´Ü±¹´ë) 
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 10:40~11:00 Influence of Obesity on the Risk of HCC in NAFLD  ¼Õ¿ø(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 11:00~11:20 Big Data Studies in NAFLD  ÀÌÁ¤ÀÏ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 11:20~11:50 Artificial Intelligence and NAFLD  Grace L. H. Wong(The Chinese Univ. of Hong Kong Hong Kong) 
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 11:50~12:10 Various Application of Image Techniques in NAFLD  À̽¼ö(¿Ã»êÀÇ´ë) 
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 12:50~13:10 Treatment Approaches in Lean NAFLD  ½Åµ¿Çö(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 13:10~13:30 Efficacy and Functionality of Probiotics in NAFLD  ¼®±âÅÂ(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 13:30~13:50 Metabolic Pharmacotherapy for NAFLD  ±è°æ¼ö(Â÷ÀÇ°úÇдë) 
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 13:50~14:10 Bariatric Surgery: Benefits and Pitfalls  ¹Ú¿µ¼®(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 14:20~14:40 Type 2 Diabetes and NAFLD  À̺´¿Ï(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 14:40~15:00 Pregnancy and Maternal NAFLD  ±è¿ø(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 15:00~15:30 Thyroid Disease and NAFLD  Donghee Kim(Stanford Univ. USA) 
±³À°½Ã°£ 10-16 ¿Â¶óÀÎ °³ÃÖ 15:30~15:50 Sarcopenia and NAFLD  ±è½Â¾÷(¿¬¼¼ÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÁö¹æ°£¿¬±¸È¸ (¿Â¶óÀÎ)KNSG NAFLD(Korean NAFLD Study Group Nonalcoholic Fatty Liver Disease) Symposium 2021 : 2021-10-16""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) ´ëÇÑ»ýÈ°½À°üº´ÇÐȸ 2021 ¿Â¶óÀÎ Ãß°èÇмú´ëȸ : 2021-10-17
´ÙÀ½±Û ±¹°¡»ý¸íÀ±¸®Á¤Ã¥¿ø (¿Â¶óÀÎ) ÀÇ·á±â°ü Á¾»çÀÚ(À§¿øȸ) ´ë»ó ¿¬¸íÀÇ·á°áÁ¤Á¦µµ ½ÉÈ­±³À° : 2021-10-15
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20559 °æ±â Á¦34Â÷ Áß¾Ó´ëÇб³ ºñ´¢ÀÇÇаú ¿öÅ©¼¥ : 2024-06-01 0 61 2024-04-29
20558 ±¤ÁÖ Á¦2ȸ ´ëÇѺñ¸¸ÇÐȸ È£³²Áöȸ Çмú´ëȸ : 2024-06-01 0 82 2024-04-29
20557 ÀÎõ 2024³â ±èÆ÷½ÃÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-06-01 0 57 2024-04-29
20556 ¼­¿ï 2024 ´ëÇÑ¿ì¿ïÇൿ½Å°æÇבּ¸È¸ Ãá°èÇмú´ëȸ : 2024-06-01 0 50 2024-04-29
20555 ¼­¿ï ´ëÇѽÉÀåÇ÷°üÈäºÎ¿Ü°úÇÐȸ Á¦38Â÷ Ãá°èÅëÇÕÇмú´ëȸ ¹× ¿¬¼ö±³À° (2ÀÏÂ÷) : 2024-06-01 0 41 2024-04-29
20554 ¼­¿ï Á¦ 14Â÷ ´ëÇѸð¹ßÀ̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ(1ÀÏÂ÷) : 2024-06-01 0 56 2024-04-29
20553 ¼­¿ï 2024³â ´ëÇѼҾư¨¿°ÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-31 0 63 2024-04-29
20552 Àü³² ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ È£³²Áöȸ - Á¦297Â÷ ¿ù·ÊÁý´ãȸ : 2024-05-31 0 75 2024-04-29
20551 ¼­¿ï (¿Â¶óÀÎ) 2024 Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-31 0 98 2024-04-29
20550 ºÎ»ê Á¦ 169Â÷ ºÎ»êÁö¹æ³²¼º°úÇÐȸ Çмú´ëȸ : 2024-05-31 0 53 2024-04-29
20549 ¼­¿ï ´ëÇѼҾư¨¿°ÇÐȸ Á¦26ȸ ¿¬¼ö°­Á : 2024-05-30 0 52 2024-04-29
20548 °­¿ø 2024³â ¿øÁÖ½ÃÀÇ»çȸ 2Â÷ ¿¬¼ö°­ÁÂ_ÃÖ±Ù ÀÇÇÐÁö°ß : 2024-05-28 0 62 2024-04-29
20547 °æ±â Á¦4ȸ ´ëÇÑ¿Ü°úÇÐȸ ¿Ü°ú³»½Ã°æ ¿¬¼ö°­Á : 2024-05-26 0 68 2024-04-29
20546 ¼­¿ï ´ëÇѺñ´¢ÃÊÀ½ÆÄÇÐȸ Á¦17Â÷ Çмú´ëȸ : 2024-05-26 0 45 2024-04-29
20545 °æºÏ 2024³âµµ °æ»óºÏµµÀÇ»çȸ Á¾ÇÕÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-26 0 75 2024-04-29
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷